Cell-surface receptors and glycosaminoglycans

Cell-surface receptors and glycosaminoglycans (GAGs) represent a diverse group of molecules on the plasma membrane of mammalian cells that facilitate essential biological processes. Glycosaminoglycans are negatively charged polysaccharides, such as heparan sulfate, that often act as co-receptors by sequestering ligands and presenting them to high-affinity signaling receptors (UniProt, 2024). This interaction is vital for signal transduction, cell adhesion, and the regulation of the extracellular matrix. In pathological contexts, GAGs and their associated receptors are frequently exploited by viruses, bacteria, and parasites as attachment factors for host cell invasion (NIH, 2023). Therapeutic strategies targeting this system often utilize GAG mimetics or decoys to block pathogen entry or modulate growth factor signaling in cancer and inflammatory diseases. Because these molecules are ubiquitously expressed, they play roles in a wide range of physiological systems, from coagulation to neural development. Drugs like heparin interact directly with these components to modulate biological activity, primarily through competitive binding (PubChem, 2024). However, the broad distribution of these targets presents significant challenges for achieving tissue-specific therapeutic effects without systemic toxicity.

Other names

Cell surface glycansHeparan sulfate proteoglycansGAGsCell surface receptor-GAG complexMembrane-associated glycosaminoglycans

Drugs typically act as competitive inhibitors or mimetics that bind to either the glycosaminoglycan chains or the receptor binding sites, thereby preventing the attachment of natural ligands, growth factors, or pathogens to the cell surface (NIH, 2023).